Dr. Andreopoulou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1283 York Avenue
New York, NY 10065- Is this information wrong?
Summary
- I am a Professor of Medicine and the Director of Breast Cancer Clinical Research at Weill Cornell Medicine/NewYork-Presbyterian Hospital where I specialize in the personalized multidisciplinary care and treatment of patients with breast cancer. I am also a member of the Englander Institute for Precision Medicine at Cornell. I previously held faculty positions at the Albert Einstein College of Medicine/ Montefiore Medical Center and the University of Texas M.D. Anderson Cancer Center. I completed my training in major academic institutions in both Europe and the U.S., including St Bartholomew’s Hospital and the Royal Marsden Hospital/Institute of Cancer Research in London, UK and the New York University School of Medicine. I was a European Society of Medical Oncology fellow. I have a special interest in individualization of patient treatment and particularly in caring for women with aggressive breast cancer. My main research interest involves precision medicine to fast-track the drug development of biologics and targeted therapy that exploit our knowledge of the cancer genome and the immuno cell network for immunotherapy in order to effectively manage, treat and cure breast cancer. I am involved with all phases of clinical drug development in all stages of the disease and I especially focus on innovative clinical trial design that incorporates cutting-edge technology.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2007
University of Ioannina Faculty of MedicineClass of 1994, MD, Cum Laude
Certifications & Licensure
NY State Medical License 2007 - 2024
TX State Medical License 2008 - 2011- ECFMG
Awards, Honors, & Recognition
- Assistant Professor of Medicine, Department of Breast Medical Oncology UT. MD Anderson Cancer Center, 2007-2010
- European Society of Medical Oncology (ESMO) Fellowship Royal Marsden Hospital/ Institute of Cancer Research, London, England
Clinical Trials
- Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer Start of enrollment: 2010 Nov 16
- Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2011 May 02
- A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Start of enrollment: 2012 Oct 03
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsRandomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Hum...Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, Prabhjot S Mundi, Elizabeth Sakach, Claire Sathe, Heejoon Ahn, Meghna S Trivedi, Yelena Novik, Amy Tiersten, Geor...> ;Journal of Clinical Oncology. 2023 Aug 20
- 4 citationsBenefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer.Genevieve A Fasano, Solange Bayard, Yalei Chen, Leticia Varella, Tessa Cigler, Jessica Bensenhaver, Rache Simmons, Alexander Swistel, Jennifer Marti, Anne Moore, Eleni...> ;Breast Cancer Research and Treatment. 2022 Feb 1
- 2 citationsFacts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer.Ashley Schreier, Roberta Zappasodi, Inna Serganova, Kristy A Brown, Sandra Demaria, Eleni Andreopoulou> ;Frontiers in Oncology. 2022 Jan 1
- Join now to see all
Press Mentions
- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
EMBCA Presents Evolution of Pharma and Biotech Industry in the 21st CenturyNovember 23rd, 2019
One-Way Texting: No Help with Breast Cancer Pill Taking, But…July 25th, 2019
Professional Memberships
- Member
Other Languages
- Greek
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York- New York-Presbyterian HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
